How immunotherapy works for cancer spread to lymph nodes
Part of Cancer clinical trials.
This study looks at real-world outcomes when patients with various cancers that have spread to lymph nodes receive immunotherapy (drugs that boost the immune system to fight cancer). Researchers want to understand which patients benefit most and what factors affect how well the treatment works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a solid cancer (lung, stomach, colon, bladder, breast, esophagus, liver, pancreas, melanoma, or similar) that has spread to lymph nodes
- Your doctor confirmed lymph node spread using imaging scans (CT, MRI, or PET-CT) or a tissue biopsy
- You have received at least one full cycle of immunotherapy (checkpoint inhibitor), either alone or combined with other drugs
- Your medical records include clear treatment dates, drug names, and doses, plus imaging scans before and after treatment
- You have documented follow-up visits and records showing how your cancer responded to treatment
- You are 18 years or older
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment using T cells taken from your lymph nodes to fight advanced solid tumors that have not responded to standard therapies. The goal is to see if this approach can help shrink tumors or slow their growth.
This trial tests a new immune cell treatment made from your own lymph nodes for advanced solid tumors that haven't responded to standard therapies or have no good treatment options. It aims to see if this personalized cell therapy is safe and can help shrink tumors.
This trial tests if a specific type of lymph node surgery, combined with a short course of immunotherapy (medicines that help your immune system fight cancer), works better for melanoma that has spread to nearby lymph nodes. It's for people whose melanoma can be removed and who are healthy enough for treatment.
This study looks at how well immunotherapy drugs (like checkpoint inhibitors) work for different cancers. If you are already planning to receive this type of treatment, researchers want to track your outcomes and see how you do over time.
This study looks at how well immunotherapy (drugs that help your immune system fight cancer) works when combined with radiation therapy. It aims to understand the benefits, risks, and what factors affect treatment success.
This trial tests injecting an immune-boosting mixture directly into a skin or lymph node tumor, along with immune-checkpoint medicines given through the vein. It aims to help the body recognize and fight advanced cancers that can’t be fully removed by surgery.
Hear when a new Malignant Solid Tumors With Lymph Node Metastasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.